You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Diamyd

Showing 1 - 18 of 18
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diabetes, Type 1, Autoimmune Diseases, Prevention Trial in Malmö (Diamyd)

Not yet recruiting
  • Diabetes Mellitus, Type 1
  • +2 more
  • Diamyd
  • Malmö, Sweden
    Lund University/CRC, Skåne University Hospital,
Jan 4, 2023

Diabetes, Type 1 Trial in Linköping (GAD-alum (Diamyd) 40 µg/mL)

Recruiting
  • Diabetes Mellitus, Type 1
  • GAD-alum (Diamyd) 40 μg/mL
  • Linköping, Sweden
    Kliniska Forskningsenheten (Hudmottagningen), Universitetssjukhu
Aug 17, 2022

Diabetes, Type 1 Trial in Sweden (GAD-Alum, Vitamin D, Etanercept)

Completed
Has Results
  • Diabetes Mellitus, Type 1
  • Helsingborg, Sweden
  • +7 more
Mar 26, 2021

Type I Diabetes Trial in Birmingham (Placebo GABA and Placebo GAD-alum, GABA and Placebo GAD-alum, Active Oral GABA and Active

Completed
  • Type I Diabetes
  • Placebo GABA and Placebo GAD-alum
  • +2 more
  • Birmingham, Alabama
    Children's of Alabama
May 2, 2022

Diabetes, Type 1, Prediabetic State Trial in Malmö (Alum-GAD, Vitamin D3)

Terminated
Has Results
  • Diabetes Mellitus, Type 1
  • Prediabetic State
  • Malmö, Sweden
    Clinical Research Center, Pediatric Endocrinology, Jan Waldenstr
Oct 27, 2020

Type 1 Diabetes Trial in Uppsala (Gamma-Aminobutyric Acid (GABA), Alprazolam)

Recruiting
  • Type 1 Diabetes Mellitus
  • Uppsala, Sweden
    Uppsala University Hospital
Sep 20, 2021

Diabetes, Type 1 Trial in Linköping (GAD-Alum, Vitamin D)

Completed
Has Results
  • Diabetes Mellitus, Type 1
  • Linköping, Sweden
    Linköping University
Apr 15, 2020

Type 1 Diabetes Trial in Canada, United States (GAD-Alum, GAD-Alum and Aluminum hydroxide, Aluminum hydroxide)

Completed
Has Results
  • Type 1 Diabetes Mellitus
  • Los Angeles, California
  • +14 more
Apr 27, 2020

Prediabetes, Type 1 Diabetes Trial in Malmö (Placebo comparator, Diamyd)

Completed
Has Results
  • Prediabetes
  • Type 1 Diabetes
  • Placebo comparator
  • Diamyd
  • Malmö, Sweden
    Clinical Research Center, Pediatric Endocrinology, Jan Waldenstr
May 2, 2019

Diabetes, Type I, Enterovirus Infections, Autoimmunity Trial in Oslo (GAD-alum, Placebo)

Terminated
  • Diabetes, Type I
  • +2 more
  • Oslo, Norway
    Endokrinologisk poliklinikk, Oslo Universitetssykehus Aker
May 14, 2018

Diabetes, Type 1 Trial in Sweden (GAD-Alum (Diamyd) 20 µg, GAD-Alum (Diamyd) 20 µg X 2, Vitamin D)

Completed
  • Diabetes Mellitus, Type 1
  • GAD-Alum (Diamyd) 20 µg
  • +3 more
  • Halmstad, Sweden
  • +9 more
Aug 22, 2017

Intractable Pain, Tumors Trial in United States (NP2, Placebo)

Completed
  • Intractable Pain
  • Neoplasms
  • NP2
  • Placebo
  • Phoenix, Arizona
  • +17 more
Jul 28, 2014

Cancer Pain Trial in United States (NP2)

Completed
  • Cancer Pain
  • NP2
  • Miami, Florida
  • +4 more
Feb 18, 2014

Diabetes Type 1, Autoimmune Diabetes Trial run by the NIDDK (Insulin, Lansoprazole, Sitagliptin)

Terminated
Has Results
  • Diabetes Mellitus Type 1
  • Autoimmune Diabetes
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 31, 2012

Type 1 Diabetes Trial in United States (rhGAD65, Placebo)

Terminated
  • Type 1 Diabetes Mellitus
  • Tucson, Arizona
  • +42 more
Oct 9, 2012

Type 1 Diabetes Trial in Worldwide (rhGAD65, Placebo)

Terminated
  • Type 1 Diabetes Mellitus
  • Helsinki, Finland
  • +69 more
Oct 7, 2011

Latent Autoimmune Diabetes in Adult (LADA) Trial in Sweden (rhGAD65 formulated in Alhydrogel® (Diamyd®))

Completed
  • Latent Autoimmune Diabetes in Adult (LADA)
  • rhGAD65 formulated in Alhydrogel® (Diamyd®)
  • Alingsås, Sweden
  • +16 more
Jun 9, 2011

Type 1 Diabetes Trial in Sweden (rhGAD65 formulated in Alhydrogel® (Diamyd®))

Completed
  • Type 1 Diabetes
  • rhGAD65 formulated in Alhydrogel® (Diamyd®)
  • Borås, Sweden
  • +7 more
Jan 29, 2008